Ausgabe 9/2004
Inhalt (7 Artikel)
Pitavastatin, a 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitor, reduces hippocampal damage after transient cerebral ischemia in gerbils
R. Kumagai, C. Oki, Y. Muramatsu, R. Kurosaki, H. Kato, T. Araki
Effects of piracetam alone and in combination with antiepileptic drugs in rodent seizure models
W. Fischer, H. Kittner, R. Regenthal, E. Russo, G. De Sarro
Aging and working memory: early deficits in EEG activation of posterior cortical areas
P. Missonnier, G. Gold, U. Leonards, L. Costa-Fazio, J.-P. Michel, V. Ibáñez, P. Giannakopoulos
Mitochondrial genotype and risk for Alzheimer’s disease: cross-sectional data from the Vienna-Transdanube-Aging “VITA” study
N. Mostafaie, W. Rossmanith, H. Hombauer, T. Dechat, T. Raffelsberger, K. Bauer, B. Worofka, E. Kittl, J. Hofmann, M. Hejtman, W. Kirchmeyr, W. Schreiber, S. Weissgram, S. Jungwirth, P. Fischer, R. Bittner, K. Huber
Impact of gender on upregulation of antioxidant defence mechanisms in Alzheimer’s disease brain
K. Schuessel, S. Leutner, N. J. Cairns, W. E. Müller, A. Eckert
Interleukin-1 gene cluster polymorphisms and risk of Alzheimer’s disease in Chinese Han population
X.-Q. Li, J.-W. Zhang, Z.-X. Zhang, D. Chen, Q.-M. Qu
Cu, Zn- and Mn-superoxide dismutase levels in brains of patients with schizophrenic psychosis
T. M. Michel, J. Thome, D. Martin, K. Nara, S. Zwerina, T. Tatschner, H. G. Weijers, E. Koutsilieri